✦ LIBER ✦

Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with etanercept, a chimeric tumor necrosis factor-alpha receptor

✍ Scribed by Mitsuaki Yanagida; Giman Jung; Yoshinori Tanaka; Saburo Sone; Maki Fujishiro; Keigo Ikeda; Kazuhisa Nozawa; Hiroshi Kaneko; Yoshinari Takasaki; Hideoki Ogawa; Kenji Takamori; Iwao Sekigawa

Book ID: 117966406
Publisher: Wiley (Blackwell Publishing)
Year: 2012
Tongue: English
Weight: 197 KB
Volume: 15
Category: Article
ISSN: 1756-1841
DOI: 10.1111/j.1756-185x.2012.01816.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction in serum levels of substance P

Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor

✍ Tomoki Origuchi; Naoki Iwamoto; Shin-ya Kawashiri; Keita Fujikawa; Toshiyuki Ara 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 334 KB

Association of tumor necrosis factor alp

Association of tumor necrosis factor alpha and its receptor polymorphisms with rheumatoid arthritis in female patients

✍ Yousri M. Hussein; Randa H. Mohamed; Heba F. Pasha; Eman E. El-Shahawy; Saad S. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Anti-tumor necrosis factor-alpha antibod

Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis

✍ Yasunori Kageyama; Eiji Torikai; Akira Nagano 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 274 KB

Treatment of sweet's syndrome with the t

Treatment of sweet's syndrome with the tumor necrosis factor antagonist etanercept in a patient with coexisting rheumatoid arthritis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Anti-tumor necrosis factor-alpha therapy

Anti-tumor necrosis factor-alpha therapy in the ordinary clinical setting: Three-year effectiveness in patients with rheumatoid arthritis

✍ Anne Grimstvedt Kvalvik; Liv Lefsaker; Siri Dyvik; Johan Gorgas Brun 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Potentiated Antibodies to Tumor Necrosis

Potentiated Antibodies to Tumor Necrosis Factor-α in the Therapy of Patients with Rheumatoid Arthritis

✍ L. V. Kozlovskaya; N. A. Mukhin; V. V. Rameev; I. A. Sarkisova; O. I. Epstein 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 294 KB